# EDGAR Filing Document

**Accession Number:** 0001655589
**File Stem:** 0000940400-26-020149
**Filing Date:** 2026-5
**Character Count:** 24862
**Document Hash:** f5637c087603331e81bcc69178f873a5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-020149.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0000940400-26-020149

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260521

**DATE AS OF CHANGE**: 20260521

**PERIOD START**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Franklin Templeton ETF Trust
- **CENTRAL INDEX KEY:** 0001655589

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23124
- **FILM NUMBER:** 261007115

**BUSINESS ADDRESS:**
- **STREET 1:** ONE FRANKLIN PARKWAY
- **CITY:** SAN MATEO
- **STATE:** CA
- **ZIP:** 94403
- **BUSINESS PHONE:** 650-312-2000

**MAIL ADDRESS:**
- **STREET 1:** ONE FRANKLIN PARKWAY
- **CITY:** SAN MATEO
- **STATE:** CA
- **ZIP:** 94403

## Series and Classes Contracts Data

### Franklin Genomic Advancements ETF (Series ID: S000067393)

| Class ID   | Class Name                        | Ticker Symbol   |
|:---|:---|:---|
| C000216720 | Franklin Genomic Advancements ETF | HELX            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Franklin Templeton ETF Trust

- **b. Investment Company Act file number:** 811-23124

- **c. CIK number of Registrant:** 0001655589

- **d. LEI of Registrant:** 549300UHXVPT5S43XV04

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** One Franklin Parkway

  - **City:** San Mateo

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94403-1906

  - **Telephone number:** 650-312-2000

**Item A.2. Information about the Series.**

- **a. Name of Series:** Franklin Genomic Advancements ETF

- **b. EDGAR series identifier (if any):** S000067393

- **c. LEI of Series:** 549300JUSHGE4MAFSG36

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-03-31

- **b. Date as of which information is reported:** 2026-03-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $21456073.72

**Total Liabilities:** $8993.93

**Net Assets:** $21447079.79

**Cash Not Reported:** $655735.10

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000216720 | 0.58%                | -5.31%               | -4.51%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-2.22                   | $55023.73                                  |
| Month 2  | $-29673.09               | $-1232645.64                               |
| Month 3  | $-170870.01              | $-841144.83                                |

### Schedule of Portfolio Investments

| Name                                           | Title                                              | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| AstraZeneca PLC                                | AstraZeneca PLC ORD USD0.25                        | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |      3695 | NS      | $728727.90    | 3.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                      | Argenx SE EUR0.10                                  | CUSIP: 000000000<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |       459 | NS      | $328316.12    | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc.                            | IQVIA Holdings Inc. COM                            | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |      1005 | NS      | $171392.70    | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| NATERA INC                                     | Natera Inc. COM                                    | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |      7131 | NS      | $1426128.69   | 6.65%             |  |  |  | No            |                  1 | On Loan: No      |
| BioNTech SE                                    | BioNTech SE SPONSORED ADS                          | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |      4340 | NS      | $385739.20    | 1.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Adaptive Biotechnologies Corp                  | Adaptive Biotechnologies Corp COM                  | CUSIP: 00650F109<br>LEI: 549300ZTF7OT1FW66Q96 | Long             | EC               | CORP              | US        |     48245 | NS      | $669640.60    | 3.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Company                   | Bristol-Myers Squibb Company COM                   | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |      1111 | NS      | $67382.15     | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Praxis Precision Medicines Inc                 | Praxis Precision Medicines Inc COM NEW             | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       667 | NS      | $214900.73    | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| HINGE HEALTH INC                               | Hinge Health, Inc. CL A                            | CUSIP: 433313103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2182 | NS      | $84137.92     | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| AnaptysBio Inc.                                | AnaptysBio Inc. COM                                | CUSIP: 032724106<br>LEI: 529900HH4WQT03IG1A12 | Long             | EC               | CORP              | US        |      2041 | NS      | $113193.86    | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corporation                            | Danaher Corporation COM                            | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |      1050 | NS      | $199080.00    | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. COM | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |      1445 | NS      | $249262.50    | 1.16%             |  |  |  | No            |                  1 | On Loan: No      |
| QIAGEN NV                                      | QIAGEN NV ORD SHARES                               | CUSIP: 000000000<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               | CORP              | NL        |      3175 | NS      | $127127.00    | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| GeneDx Holdings Corp                           | GeneDx Holdings Corp COM CL A                      | CUSIP: 81663L200<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1409 | NS      | $90485.98     | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Caredx Inc                                     | Caredx Inc COM                                     | CUSIP: 14167L103<br>LEI: 549300NQOFKL9NON0U06 | Long             | EC               | CORP              | US        |      7429 | NS      | $128967.44    | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics Inc                       | Travere Therapeutics Inc COM                       | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10129 | NS      | $300932.59    | 1.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Repligen Corporation                           | Repligen Corporation COM                           | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |      1866 | NS      | $219852.12    | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Corteva Inc                                    | Corteva Inc COM                                    | CUSIP: 22052L104<br>LEI: 549300WZN9I2QKLS0O94 | Long             | EC               | CORP              | US        |      6904 | NS      | $577933.84    | 2.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc.                   | Alnylam Pharmaceuticals Inc. COM                   | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |      1687 | NS      | $558177.69    | 2.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies Inc.                      | Agilent Technologies Inc. COM                      | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |      1136 | NS      | $129481.28    | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| BEAM THERAPEUTICS INC                          | Beam Therapeutics Inc. COM                         | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7036 | NS      | $167667.88    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                                     | Insmed Inc COM PAR $.01                            | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |      5932 | NS      | $970000.64    | 4.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corporation                   | Twist Bioscience Corporation COM                   | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |      7184 | NS      | $341383.68    | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc                     | Rhythm Pharmaceuticals Inc COM                     | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |       974 | NS      | $84708.78     | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Veracyte Inc                                   | Veracyte Inc COM                                   | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |      6788 | NS      | $218641.48    | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals, Inc.                | Regeneron Pharmaceuticals, Inc. COM                | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       748 | NS      | $577934.72    | 2.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Sartorius AG                                   | Sartorius AG NON VTG PFD NPV                       | CUSIP: 000000000<br>LEI: 529900EQV2DY4FOAMU38 | Long             | EP               | CORP              | DE        |       841 | NS      | $205331.11    | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Incorporated            | Ligand Pharmaceuticals Incorporated COM NEW        | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |      3794 | NS      | $757472.10    | 3.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Krystal Biotech Inc                            | Krystal Biotech Inc COM                            | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |      4418 | NS      | $1141257.76   | 5.32%             |  |  |  | No            |                  1 | On Loan: No      |
| BEONE MEDICINES LTD                            | BeOne Medicines Ltd. SPONSORED ADS                 | CUSIP: 07725L102<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | CH        |       209 | NS      | $62066.73     | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics, Inc.                         | PTC Therapeutics, Inc. COM                         | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |      4652 | NS      | $316940.76    | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Rad Laboratories, Inc.                     | Bio-Rad Laboratories, Inc. CL A                    | CUSIP: 090572207<br>LEI: 549300ZC1GPV35XYDK53 | Long             | EC               | CORP              | US        |       226 | NS      | $62997.50     | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Caris Life Sciences Inc.                       | Caris Life Sciences Inc. COM                       | CUSIP: 142152107<br>LEI: 549300LX5LO78M5VPY43 | Long             | EC               | CORP              | US        |       557 | NS      | $9959.16      | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                            | Guardant Health Inc COM                            | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     15718 | NS      | $1451871.66   | 6.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Incorporated            | Vertex Pharmaceuticals Incorporated COM            | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |      1435 | NS      | $640784.90    | 2.99%             |  |  |  | No            |                  1 | On Loan: No      |
| ARCUTIS BIOTHERAPEUTICS INC                    | Arcutis Biotherapeutics Inc. COM                   | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4107 | NS      | $96760.92     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co.                                | Eli Lilly & Co. COM                                | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |       593 | NS      | $545423.61    | 2.54%             |  |  |  | No            |                  1 | On Loan: No      |
| GRAIL Inc                                      | GRAIL Inc COM                                      | CUSIP: 384747101<br>LEI: 2549009XSNESW3VE8024 | Long             | EC               | CORP              | US        |      4138 | NS      | $213851.84    | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc.                       | Axsome Therapeutics Inc. COM                       | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |       566 | NS      | $95665.32     | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| OMNIAB INC                                     | OmniAb Inc. USD0.0001 A (USD15 VESTING)            | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       240 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Tempus AI Inc.                                 | Tempus AI Inc. CL A                                | CUSIP: 88023B103<br>LEI: 2549009LA0KWRAGQBX50 | Long             | EC               | CORP              | US        |      8726 | NS      | $394589.72    | 1.84%             |  |  |  | No            |                  1 | On Loan: No      |
| TransMedics Group Inc.                         | TransMedics Group Inc. COM                         | CUSIP: 89377M109<br>LEI: 549300060GVOSMWARH50 | Long             | EC               | CORP              | US        |       482 | NS      | $47915.62     | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Samsung Biologics Co Ltd                       | Samsung Biologics Co Ltd KRW2500                   | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |       652 | NS      | $640229.82    | 2.99%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corporation                | United Therapeutics Corporation COM                | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |      1680 | NS      | $996206.40    | 4.64%             |  |  |  | No            |                  1 | On Loan: No      |
| OMNIAB INC                                     | OmniAb Inc. USD0.0001 A (USD12.5 VESTING)          | CUSIP: 68218J202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       240 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Medpace Holdings Inc.                          | Medpace Holdings Inc. COM                          | CUSIP: 58506Q109<br>LEI: 549300H8TYEUVTW14A54 | Long             | EC               | CORP              | US        |      1327 | NS      | $637212.13    | 2.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc                     | Tarsus Pharmaceuticals Inc COM                     | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1487 | NS      | $104313.05    | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalyst Pharmaceuticals Inc.                  | Catalyst Pharmaceuticals Inc. COM                  | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |      6375 | NS      | $157845.00    | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Stoke Therapeutics Inc                         | Stoke Therapeutics Inc COM                         | CUSIP: 86150R107<br>LEI: 549300RD25SS2DIJHJ67 | Long             | EC               | CORP              | US        |     10539 | NS      | $343149.84    | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc                           | Bridgebio Pharma Inc COM                           | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |     12192 | NS      | $905377.92    | 4.22%             |  |  |  | No            |                  1 | On Loan: No      |
| SAMSUNG EPIS HOLDINGS CO LTD                   | Samsung Epis Holdings KRW2500                      | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |       350 | NS      | $112884.80    | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc                   | Thermo Fisher Scientific Inc COM                   | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |       391 | NS      | $192188.23    | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceuticals Inc                 | Ultragenyx Pharmaceuticals Inc COM                 | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |      4765 | NS      | $99826.75     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG                         | CRISPR Therapeutics AG NAMEN AKT                   | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |      4671 | NS      | $222199.47    | 1.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC                       | Jazz Pharmaceuticals PLC SHS USD                   | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |       841 | NS      | $158991.05    | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Cadence Design Systems, Inc.                   | Cadence Design Systems, Inc. COM                   | CUSIP: 127387108<br>LEI: GCT7RXJOGLXPV0NXZY22 | Long             | EC               | CORP              | US        |       545 | NS      | $151439.15    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                     | Neurocrine Biosciences Inc COM                     | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |      2693 | NS      | $354775.82    | 1.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurogene Inc.                                 | Neurogene Inc. COM                                 | CUSIP: 64135M105<br>LEI: 529900A7VIY892SZVW73 | Long             | EC               | CORP              | US        |      1840 | NS      | $37094.40     | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Wave Life Sciences Ltd.                        | Wave Life Sciences Ltd. SHS                        | CUSIP: 000000000<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | SG        |      4470 | NS      | $32407.50     | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Recursion Pharmaceuticals Inc                  | Recursion Pharmaceuticals Inc CL A                 | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10393 | NS      | $31906.51     | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals, Inc.                    | Ionis Pharmaceuticals, Inc. COM                    | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |      5957 | NS      | $447311.13    | 2.09%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-05-21

**Name of Applicant:** Franklin Templeton ETF Trust

**Signature:** Monica Krogh

**Name of Signer:** Monica Krogh

**Title:** Assistant Treasurer Controller, US Fund Administration and Oversight